Lymphoma Study Sees Early Promise in Pathway Targeting Cancerous B-Cells
News
Wistar Institute researchers recently discovered that a protein in the endoplasmic reticulum, called STING, can stimulate the immune system to kill malignant B-cells — the cause of several lymphomas. The ... Read more